Department of Biomedical Sciences, University of Padova, Viale G. Colombo 3, 35121, Padua, Italy.
Institute of Biosciences and Medical Technology, Tampere, Finland.
Amino Acids. 2019 Nov;51(10-12):1461-1474. doi: 10.1007/s00726-019-02781-8. Epub 2019 Sep 4.
We present an in silico characterization of the von Hippel-Lindau-like protein (VLP), the only known human paralog of the von Hippel-Lindau tumor suppressor protein (pVHL). Phylogenetic investigation showed VLP to be mostly conserved in upper mammals and specifically expressed in brain and testis. Structural analysis and molecular dynamics simulations show VLP to be very similar to pVHL three-dimensional organization and binding dynamics. In particular, conservation of elements at the protein interfaces suggests VLP to be a functional pVHL homolog potentially possessing multiple functions beyond HIF-1α-dependent binding activity. Our findings show that VLP may share at least seven interactors with pVHL, suggesting novel functional roles for this understudied human protein. These may occur at precise hypoxia levels where functional overlap with pVHL may permit a finer modulation of pVHL functions.
我们对类 von Hippel-Lindau 蛋白(VLP)进行了计算机模拟分析,它是已知的 von Hippel-Lindau 肿瘤抑制蛋白(pVHL)的唯一人类同源物。系统发育研究表明,VLP 在高等哺乳动物中大多是保守的,特别是在大脑和睾丸中表达。结构分析和分子动力学模拟表明,VLP 与 pVHL 的三维结构组织和结合动力学非常相似。特别是,蛋白质界面元素的保守性表明,VLP 是一个具有多种功能的功能性 pVHL 同源物,其功能可能不仅仅局限于依赖 HIF-1α的结合活性。我们的研究结果表明,VLP 可能与 pVHL 至少有七个相互作用因子,这表明这个研究较少的人类蛋白可能具有新的功能作用。这些作用可能发生在特定的低氧水平,功能上与 pVHL 的重叠可能允许对 pVHL 功能进行更精细的调节。